An Immunomodulatory Formulation consisting of Nf-Kappa B , TNF-A and IL-6 Suppressive Protopanaxatriol Class Glucopyranoside Analouges, A Neurotrophic Protobioside Analouge that Promotes Myelin Regeneration , A Myotrophic Bioceutical Extract with Partial SARM-Like Effects thus increasing Muscle Mass via Protein Synthesis Enhancement , via GDF-8 Suppression, increasing intramascular MGF and IGF-1 mRNA Expression and Enhancing Cholinergic Neuromascular Transmission Duration. By Inhibiting Pro-Inflammatory Cytokine Release and via increasing Selective Anabolism Formulation Serves as an Effective Adjunctive Treatment for ALS and Multiple Sclerosis.

Inventors : Erdal Can ALKOCLAR

Metehan YESIl

Resources

201305306.pdf

Novelty Report & Scientific Research Abstracts

16-ms-ve-als.docx

Patent Content & Mechanism of Action and Compound Description

Discussions

Discussion between the organization and the community about this dataset.

Community resources

You have built a more comprehensive database than those presented here? This is the time to share it!

Reuses

You reused these data and published an article, a computer graphics, or an application? It's time to let you know! Reference your work in just a few clicks and increase your visibility.